Barriers to measuring the effectiveness of drug policy Patrick R. CliffordThomas Nicholson Articles Pages: 363 - 374
Uses and misuses of epidemiology in shaping and assessing drug policy David F. Duncan Articles Pages: 375 - 382
Alternatives to U.S. drug policy Evan S. DellonDavid C. LewisCamille A. Gear Articles Pages: 383 - 406
Science, scientists, and drug policy: A conversation with harry Steven Jonas Articles Pages: 407 - 411
Editorial: Is prevention more than brand name recognition? David C. LewisDavid F. Duncan Articles Pages: 413 - 415